RecruitingNCT06487754
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Sponsor
University Hospital, Grenoble
Enrollment
15 participants
Start Date
Sep 27, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- living close to Grenoble
- having pelvic pain that appeared or were modified after taking GAHT
Exclusion Criteria1
- Subject under guardianship or subject deprived of liberty Refusal of voice recording
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06487754
Related Trials
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
NCT056127505 locations
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
NCT0695522129 locations
High-Intensity Interval Training and Menstrual Health Experience in Primary Dysmenorrhea.
NCT073919301 location
Acupuncture for Chronic Pelvic Pain
NCT063885901 location
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
NCT037944661 location